Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
- PMID: 10499587
- DOI: 10.1038/45809
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
Erratum in
- Nature 1999 Dec 23-30;402(6764):898
Abstract
Urotensin-II (U-II) is a vasoactive 'somatostatin-like' cyclic peptide which was originally isolated from fish spinal cords, and which has recently been cloned from man. Here we describe the identification of an orphan human G-protein-coupled receptor homologous to rat GPR14 and expressed predominantly in cardiovascular tissue, which functions as a U-II receptor. Goby and human U-II bind to recombinant human GPR14 with high affinity, and the binding is functionally coupled to calcium mobilization. Human U-II is found within both vascular and cardiac tissue (including coronary atheroma) and effectively constricts isolated arteries from non-human primates. The potency of vasoconstriction of U-II is an order of magnitude greater than that of endothelin-1, making human U-II the most potent mammalian vasoconstrictor identified so far. In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primates, a response associated with profound cardiac contractile dysfunction. Furthermore, as U-II immunoreactivity is also found within central nervous system and endocrine tissues, it may have additional activities.
Similar articles
-
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.Biochem Biophys Res Commun. 1999 Dec 9;266(1):174-8. doi: 10.1006/bbrc.1999.1796. Biochem Biophys Res Commun. 1999. PMID: 10581185
-
A new ligand for the urotensin II receptor.Br J Pharmacol. 2002 Oct;137(3):311-4. doi: 10.1038/sj.bjp.0704895. Br J Pharmacol. 2002. PMID: 12237249 Free PMC article.
-
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):141-9. doi: 10.1007/s00210-001-0503-0. Epub 2001 Nov 20. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 11819032
-
[A vasoactive peptide: urotensin II].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Aug;27(4):525-8. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005. PMID: 16178453 Review. Chinese.
-
Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor.Curr Med Chem. 2004 Apr;11(8):969-79. doi: 10.2174/0929867043455495. Curr Med Chem. 2004. PMID: 15078159 Review.
Cited by
-
Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells.Vasc Health Risk Manag. 2010 Sep 7;6:723-34. doi: 10.2147/vhrm.s11129. Vasc Health Risk Manag. 2010. PMID: 20859543 Free PMC article.
-
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-α induced by urotensin II.J Zhejiang Univ Sci B. 2022 Dec 15;23(12):1014-1027. doi: 10.1631/jzus.B2200346. J Zhejiang Univ Sci B. 2022. PMID: 36518054 Free PMC article.
-
Urotensin-II induces ear flushing in rats.Br J Pharmacol. 2007 Feb;150(4):415-23. doi: 10.1038/sj.bjp.0707006. Epub 2007 Jan 8. Br J Pharmacol. 2007. PMID: 17211454 Free PMC article.
-
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.Br J Pharmacol. 2004 Jul;142(6):921-32. doi: 10.1038/sj.bjp.0705743. Epub 2004 Jun 21. Br J Pharmacol. 2004. PMID: 15210573 Free PMC article.
-
Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.BMC Nephrol. 2017 Mar 31;18(1):113. doi: 10.1186/s12882-017-0530-9. BMC Nephrol. 2017. PMID: 28359257 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases